Taylor Lorenz on Nostr: "If a strain other than JN.1 is selected [for the updated vaccine] this late in the ...
Published at
2024-05-24 21:34:37Event JSON
{
"id": "5776a2de487b2983206e47f813d1994c8b240475349bb0b96f30b63276b58088",
"pubkey": "696736ec91f9b497bf0480f73530abd5c4a3bf8e261cfb23096dd88297a2190f",
"created_at": 1716586477,
"kind": 1,
"tags": [
[
"proxy",
"https://mastodon.social/users/taylorlorenz/statuses/112498211398883426",
"activitypub"
]
],
"content": "\"If a strain other than JN.1 is selected [for the updated vaccine] this late in the development process, a protein-based option will not be available for the U.S. population,\" Novavax said https://www.yahoo.com/news/novavax-awaits-fda-decision-whether-201925046.html",
"sig": "a8b5d024ec9cf1a712ba85e1d9507d76181b5b7d43b1bc139cafe264011be65d529a71d6016c5a32194b87887236edf8d1a0a810f5a02b0b9a4a57e2b1b45b6b"
}
